Gaupp S, Hartung H P, Toyka K, Jung S
Department of Neurology, Julius-Maximilians Universität Würzburg, Germany.
J Neuroimmunol. 1997 Nov;79(2):129-37. doi: 10.1016/s0165-5728(97)00115-x.
Experimental autoimmune neuritis (EAN) in Lewis rats is a T cell-mediated disease and serves as an animal model of human inflammatory demyelinating neuropathies. EAN can be induced by immunization with complete bovine peripheral nerve myelin (BPM), the myelin protein P2 or its neuritogenic peptide, each emulsified in complete Freund's adjuvant (CFA). The present study evaluates the effect of oral tolerization with BPM or P2 protein on the development of actively induced EAN. Oral administration of BPM strongly suppressed clinical and histological signs of EAN subsequently induced by BPM/CFA, but feeding of P2 protein alone did not affect its course. In contrast, feeding of BPM did not mitigate the course of EAN subsequently induced by immunization with neuritogenic P2 peptide/CFA. Oral therapy with BPM after onset of myelin-induced EAN only slightly ameliorated the further course of disease, but significantly reduced lethality of this severe form of disease. The findings suggest that immunogenicity of the antigens fed determine strength of tolerance, that downregulation of EAN occurs at the site of immunization and not in the nerve, and that active suppression rather than specific anergization is operative in mediating resistance to EAN. However, only partial tolerance to myelin-induced EAN was achieved in naive animals by transfer of spleen/LN cells from rats orally tolerized with BPM. Although methodic factors may have limited the effect of the cells, the result is suggestive of some contribution of anergy to oral tolerance in the present model. Cholera toxin and LPS were identified as oral adjuvants for BPM and prolonged the state of tolerance. However, LPS exhibited proinflammatory properties if EAN was induced early after BPM/LPS-feeding. Thus, oral application of a mixture of myelin components in combination with cholera toxin may be a useful treatment for chronic inflammatory neuropathies considered autoimmune in nature.
实验性自身免疫性神经炎(EAN)在Lewis大鼠中是一种T细胞介导的疾病,可作为人类炎性脱髓鞘性神经病的动物模型。用完全牛周围神经髓磷脂(BPM)、髓磷脂蛋白P2或其神经原性肽进行免疫接种均可诱发EAN,每种抗原均乳化于完全弗氏佐剂(CFA)中。本研究评估口服BPM或P2蛋白诱导耐受对主动诱导的EAN发展的影响。口服BPM可强烈抑制随后由BPM/CFA诱导的EAN的临床和组织学症状,但单独喂食P2蛋白对其病程没有影响。相反,喂食BPM并不能减轻随后用神经原性P2肽/CFA免疫诱导的EAN的病程。髓磷脂诱导的EAN发病后口服BPM治疗仅略微改善了疾病的进一步发展过程,但显著降低了这种严重疾病形式的致死率。这些发现表明,喂食抗原的免疫原性决定了耐受的强度,EAN的下调发生在免疫部位而非神经中,并且在介导对EAN的抗性中起作用的是主动抑制而非特异性无反应性。然而,通过转移口服BPM诱导耐受的大鼠的脾/LN细胞,在未免疫动物中仅实现了对髓磷脂诱导的EAN的部分耐受。尽管方法学因素可能限制了细胞的作用,但该结果提示在本模型中无反应性对口服耐受有一定贡献。霍乱毒素和LPS被确定为BPM的口服佐剂,并延长了耐受状态。然而,如果在喂食BPM/LPS后早期诱导EAN,LPS表现出促炎特性。因此,口服髓磷脂成分与霍乱毒素的混合物可能是治疗本质上被认为是自身免疫性的慢性炎性神经病的一种有用方法。